NTLA
Intellia Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +16.7% ·
share flow -0.6% ·
net new positions +14.3%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 108 | +3 | 103.12M | $1.74B | +8 | −5 |
| Q1 2026 | 108 | +4 | 82.71M | $1.06B | +13 | −9 |
| Q4 2025 | 104 | -1 | 82.78M | $744.21M | +1 | −2 |
| Q3 2025 | 18 | +2 | 59.30M | $1.02B | +2 | −1 |
| Q2 2025 | 14 | +2 | 47.63M | $446.74M | +2 | — |
| Q1 2025 | 9 | -4 | 25.51M | $181.35M | — | −4 |
| Q4 2024 | 13 | +3 | 26.17M | $305.16M | +3 | — |
| Q3 2024 | 9 | 0 | 18.08M | $371.64M | +1 | −1 |
| Q2 2024 | 9 | — | 17.86M | $399.79M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 13.02M | +0.1% | $122.11M | 0.9% | ▲ Add | 5 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passive) | 10.85M | — | $101.79M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passive) | 10.85M | — | $101.79M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passive) | 10.85M | — | $101.79M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passive) | 10.85M | — | $101.79M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passive) | 10.85M | — | $101.79M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passive) | 10.03M | — | $94.05M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passive) | 4.04M | -10.4% | $37.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passive) | 2.61M | +5.1% | $24.45M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passive) | 2.61M | +5.1% | $24.45M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 2.28M | +14.2% | $21.35M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 1.52M | — | $14.26M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 1.52M | — | $14.26M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Millennium Management ✦ | 831.01K | +41.7% | $7.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 824.73K | +2445.8% | $7.74M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 709.98K | -74.2% | $6.66M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Renaissance Technologies ✦ | 676.90K | New | $6.35M | 0.0% | New | 1 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 136.54K | +50.2% | $1.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 136.54K | +50.2% | $1.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 136.54K | +50.2% | $1.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 136.54K | +50.2% | $1.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 37 | Norges Bank ✦ (passive) | 56.94K | New | $534,088 | 0.0% | New | 1 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 51.13K | +16.5% | $480,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $6.35M | 0.0% |
| Norges Bank | $534,088 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 22.80K shares, $292 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 2.79K sh · $36,205
Officer, Director · 19.89K sh · $250,614
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology